Clearpoint Neuro Inc (CLPT) Stock Price, Quote & News

Company Profile

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 287 9109

Website: www.clearpointneuro.com

Address:

120 S. Sierra Avenue, Suite 100, Solana Beach, United States

Thinkingman91 Jun. 3 at 7:05 PM

$CLPT weeeeeee

0 · Reply

NY2CHI Jun. 3 at 6:23 PM

$CLPT Looking like the FDA is going to change course on Qure's AMT130. If so, we're going back over $20 very quickly. Still can't believe the FDA's rug pull last fall. At least it created a fantastic buying opp....

1 · Reply

MAGA1717 Jun. 3 at 2:20 PM

$CLPT 🤡🤡🤡🤡🤡👇

0 · Reply

LotOfAction Jun. 3 at 1:46 PM

$QURE $CLPT

0 · Reply

Twister8 Jun. 3 at 2:59 AM

$CLPT what meaningless news is Joe gonna produce next?

0 · Reply

0dte_Gambler Jun. 2 at 8:47 PM

$CLPT Any near term catalysts? I just have a tiny position in this.

0 · Reply

Twister8 Jun. 1 at 2:43 PM

$CLPT whats new in spaghetti world?

0 · Reply

Arcides May. 29 at 5:48 PM

$CLPT a lot of volume

1 · Reply

Twister8 May. 29 at 3:09 PM

$CLPT pump and dump this hyped horseshit.

0 · Reply

NY2CHI May. 29 at 1:48 PM

$CLPT queue TJ @Twister8 to claim he went back long lol

0 · Reply

ClearPoint Neuro enters development partnership with Sungkyunkwan University

May 27, 2026, 4:30 PM EDT - 7 days ago

ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-05-13T21:56:29.000Z - 21 days ago

ClearPoint Neuro receives CE Marking for Velocity Alpha MR

2026-05-13T21:26:39.000Z - 21 days ago

ClearPoint Neuro reports Q1 EPS (32c) vs. (22c) last year

2026-05-13T21:24:39.000Z - 21 days ago

ClearPoint Neuro sees FY26 revenue $52M-$56M, consensus $53.03M

May 13, 2026, 4:30 PM EDT - 21 days ago

ClearPoint Neuro Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 21 days ago

ClearPoint Neuro Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 21 days ago

ClearPoint Neuro Quarterly report: Q1 2026

May 13, 2026, 4:05 PM EDT - 21 days ago

ClearPoint Neuro Reports First Quarter 2026 Results

May 13, 2026, 4:00 PM EDT - 21 days ago

ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint

May 13, 2026, 7:00 AM EDT - 21 days ago

ClearPoint Neuro Slides: Investor presentation

2026-05-08T13:16:56.000Z - 26 days ago

ClearPoint Neuro resumed with a Buy at Stifel

Apr 29, 2026, 4:05 PM EDT - 5 weeks ago

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

Apr 23, 2026, 8:00 AM EDT - 5 weeks ago

ClearPoint Neuro Proxy statement: Proxy filing

2026-04-22T21:06:43.000Z - 6 weeks ago

ClearPoint Neuro announces first clinical use of Velocity Alpha MR drill

Apr 22, 2026, 4:05 PM EDT - 6 weeks ago

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-04-20T20:16:48.000Z - 6 weeks ago

ClearPoint Neuro announces Canadian approval for Neuro Navigation System

Apr 20, 2026, 4:05 PM EDT - 6 weeks ago

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

Apr 10, 2026, 8:00 AM EDT - 7 weeks ago

ClearPoint Neuro Proxy statement: Proxy filing

2026-03-18T12:50:37.000Z - 2 months ago

ClearPoint Neuro price target raised to $20 from $18 at B. Riley

Mar 17, 2026, 4:30 PM EDT - 2 months ago

ClearPoint Neuro Earnings Call Transcript: Q4 2025

Mar 17, 2026, 4:30 PM EDT - 2 months ago

ClearPoint Neuro Annual report: Q4 2025

Mar 17, 2026, 4:30 PM EDT - 2 months ago

ClearPoint Neuro Earnings release: Q4 2025

Mar 17, 2026, 4:05 PM EDT - 2 months ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

Mar 17, 2026, 7:00 AM EDT - 2 months ago

ClearPoint Neuro Slides: Corporate presentation

Mar 6, 2026, 8:00 AM EST - 3 months ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

2026-03-05T14:22:39.000Z - 3 months ago

ClearPoint Neuro price target lowered to $18 from $28 at B. Riley

QURE

Jan 22, 2026, 4:30 PM EST - 4 months ago

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

2026-01-14T21:11:05.000Z - 5 months ago

ClearPoint Neuro files to sell 1.31M shares of common stock for holders

Jan 14, 2026, 7:00 AM EST - 5 months ago

ClearPoint Neuro Registration statement: Registration Filing

2026-01-12T14:41:40.000Z - 5 months ago

ClearPoint Neuro sees Q4 revenue $10.4M, up 20% y/y

2026-01-12T14:41:28.000Z - 5 months ago

ClearPoint Neuro sees FY26 revenue $54M-$60M

Jan 12, 2026, 8:30 AM EST - 5 months ago

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Nov 20, 2025, 5:00 PM EST - 6 months ago

ClearPoint Neuro Completes Acquisition of IRRAS

2025-11-06T22:45:29.000Z - 7 months ago

ClearPoint Neuro acquires Irras Holdings, terms undisclosed

Nov 6, 2025, 4:55 PM EST - 7 months ago

ClearPoint Neuro Reports Third Quarter 2025 Results

Nov 6, 2025, 4:50 PM EST - 7 months ago

ClearPoint Neuro Announces Agreement to Acquire IRRAS

Nov 6, 2025, 4:30 PM EST - 7 months ago

ClearPoint Neuro Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

ClearPoint Neuro Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 7 months ago

ClearPoint Neuro Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 7 months ago

ClearPoint Neuro Slides: Investor Presentation

Nov 5, 2025, 5:02 PM EST - 7 months ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

Oct 7, 2025, 4:15 PM EDT - 8 months ago

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 6, 2025, 4:10 PM EDT - 8 months ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

2025-10-03T12:56:49.000Z - 8 months ago

Why Is ClearPoint Neuro Stock (CLPT) Up Today?

Oct 1, 2025, 4:05 PM EDT - 8 months ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Sep 25, 2025, 4:05 PM EDT - 8 months ago

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 4, 2025, 4:05 PM EDT - 9 months ago

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Aug 12, 2025, 4:30 PM EDT - 10 months ago

ClearPoint Neuro Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

ClearPoint Neuro Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 10 months ago

ClearPoint Neuro Earnings release: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 10 months ago

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 12, 2025, 7:00 AM EDT - 10 months ago

ClearPoint Neuro Slides: Investor Presentation

Aug 4, 2025, 4:05 PM EDT - 10 months ago

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Jul 23, 2025, 4:05 PM EDT - 11 months ago

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

May 13, 2025, 4:40 PM EDT - 1 year ago

ClearPoint Neuro Reports First Quarter 2025 Results

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings release: Q1 2025

May 12, 2025, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Apr 25, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Apr 9, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro Proxy statement: Proxy Filing

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Annual report: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings release: Q4 2024

Feb 26, 2025, 4:30 PM EST - 1 year ago

ClearPoint Neuro Slides: Q4 2024

Feb 26, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 14, 2025, 8:00 AM EST - 1 year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 12, 2025, 4:15 PM EST - 1 year ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Jan 27, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Nov 13, 2024, 6:15 PM EST - 1 year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

ClearPoint Neuro Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

Oct 31, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Aug 26, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Aug 7, 2024, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Quarterly report: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Earnings release: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 1 year ago

ClearPoint Neuro Slides: Q2 2024

Jul 17, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

Jun 20, 2024, 8:45 AM EDT - 2 years ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 20, 2024, 8:30 AM EDT - 2 years ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

Jun 1, 2024, 9:00 AM EDT - 2 years ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Quarterly report: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q1 2024

Apr 16, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Apr 5, 2024, 8:00 AM EDT - 2 years ago

ClearPoint Neuro Proxy statement: Proxy Filing

Mar 19, 2024, 8:07 AM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings Call Transcript: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Annual report: Q4 2023

Mar 12, 2024, 4:30 PM EDT - 2 years ago

ClearPoint Neuro Earnings release: Q4 2023

Mar 12, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Mar 1, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

Feb 29, 2024, 8:00 AM EST - 2 years ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

Feb 28, 2024, 4:45 PM EST - 2 years ago

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

Jan 25, 2024, 12:00 PM EST - 2 years ago

ClearPoint Neuro Transcript: Status Update

Jan 24, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

Jan 22, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

Jan 8, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

Thinkingman91 Jun. 3 at 7:05 PM

$CLPT weeeeeee

0 · Reply

NY2CHI Jun. 3 at 6:23 PM

1 · Reply

MAGA1717 Jun. 3 at 2:20 PM

$CLPT 🤡🤡🤡🤡🤡👇

0 · Reply

LotOfAction Jun. 3 at 1:46 PM

$QURE $CLPT

0 · Reply

Twister8 Jun. 3 at 2:59 AM

$CLPT what meaningless news is Joe gonna produce next?

0 · Reply

0dte_Gambler Jun. 2 at 8:47 PM

$CLPT Any near term catalysts? I just have a tiny position in this.

0 · Reply

Twister8 Jun. 1 at 2:43 PM

$CLPT whats new in spaghetti world?

0 · Reply

Arcides May. 29 at 5:48 PM

$CLPT a lot of volume

1 · Reply

Twister8 May. 29 at 3:09 PM

$CLPT pump and dump this hyped horseshit.

0 · Reply

NY2CHI May. 29 at 1:48 PM

$CLPT queue TJ @Twister8 to claim he went back long lol

0 · Reply

JFais May. 29 at 1:32 PM

$XBI AM theme: there may be hope for this FDA yet 🙌 Greater regulatory flexibility could further boost valuations in rare disease, oncology & other areas as PoS estimates are hiked across the board $REPL $QURE $CLPT Ie. $IOVA now has clearer path to market for NSCLC then sarcoma & endometrial given reliance on single arm AA studies

1 · Reply

JFais May. 29 at 1:07 PM

$QURE $CLPT good sympathy plays on this news as well (near-term tailwind)

0 · Reply

Reapthewhirlwind69 May. 29 at 12:49 PM

$CLPT

0 · Reply

MAGA1717 May. 29 at 12:18 PM

$CLPT 🤡🤡🤡🤡🤡👇

1 · Reply

LotOfAction May. 29 at 11:42 AM

$CLPT the Makary out thesis is starting to play out $QURE $REPL

0 · Reply

MAGA1717 May. 28 at 5:35 PM

$CLPT heading to all time new high this year

1 · Reply

LotOfAction May. 28 at 3:01 PM

$CLPT I love this FUS move - it’s a great technology with applications on its own or in concert with drug treatments given simultaneously Where I work we have to send patients to facilities in other countries in order to access it. If Clearpoint can ease that access I am in no doubt the therapeutic applications are there. Quietly becoming a one stop shop for CNS therapeutics. LONG

0 · Reply

nomen May. 27 at 9:08 PM

$CLPT HUGE NEWS. Focused ultrasound was a longer term weak spot for ClearPoint in drug delivery, now their install base will have a solution as well. This is going to 5-10b longer term

1 · Reply

Twister8 May. 27 at 8:39 PM

$CLPT lol, Joe throwing more spaghetti, meaningless without revenue attached.

0 · Reply

Twister8 May. 22 at 6:32 PM

$CLPT Joe checking his emails to see if any of his “partners” can help move Clpt stock higher…

1 · Reply

Twister8 May. 20 at 5:16 PM

$CLPT What is the catalyst for growth? hoping one of their biotech "partners" advances with regulatory approvals for a large patient population needing a therapy delivered via a brain cannula?

1 · Reply

Twister8 May. 18 at 9:40 PM

$CLPT seeing the pumpers try to convince others this is more than just a spaghetti toss play is humorous…

1 · Reply

Market Cap	370.98M
Revenue (ttm)	36.97M
Net Income (ttm)	-25.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-69.08%
Debt to Equity Ratio	2.63

Volume	741,700
Avg Vol	582,188
Day's Range	N/A - N/A
Shares Out	29.99M
Stochastic %K	72%
Beta	1.31
Analysts	Strong Sell
Price Target	$22.00